Prot#SERES-201: ECO-RESET: A Phase 2B, Randomized, Double Blind, Placebo-Controlled, Multiple Dose, Multicenter Study to Assess Efficacy and Safety of SER-287 in Adults with Active Mild-to Moderate Ulcerative Colitis

Project: Research project

Project Details

StatusFinished
Effective start/end date2/3/20 → 2/3/23

Funding

  • Quintiles, Inc. (Prot#SERES-201)
  • Seres Therapeutics, Inc. (Prot#SERES-201)